Table 1.
Demographic and biometric characteristics of the patients.
| Variables* | Control Group (n=24) | Group NS-1 (n=26) | Group NS-2 (n=26) |
|---|---|---|---|
|
| |||
| Age (years) | 37.1 (11.2) | 37.5 (12.7) | 39.2 (13.6) |
| Male, n (%) | 9 (37.5) | 8 (30.8) | 9 (34.6) |
| Female, n (%) | 15 (62.5) | 18 (69.2) | 17 (65.4) |
| Height (m) | 1.58 (0.09) | 1.60 (0.1) | 1.60 (0.07) |
| Weight (kg) | 75.49 (15.5) | 77.12 (19.5) | 78.28 (15.2) |
| BMI (kg/m2) | 30.1 (6.0) | 30.6 (8.8) | 30.4 (5.2) |
| Asthma duration (years) | 13.3 (8.5) | 10.3 (8.9) | 13.1 (6.4) |
| Atopic asthma n (%) | 14 (58.3) | 12 (46.2) | 12 (46.2) |
Data is presented as (mean±SD) for all variables. No statistically significant differences between treatment groups. Control: Placebo group, NS-1: 1 g/day Nigella sativa, NS-2: 2 g/day Nigella sativa